Protein kinase C inhibitors alter neurotensin receptor binding and function in prostate cancer PC3 cells

Regulatory Peptides

Volumn 147, Issue 1-3, 2008, Pages 96-109

  Carraway, Robert E ^a   Hassan, Sazzad ^a   Dobner, Paul R ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

G protein receptor binding; G protein receptor signaling; Neurotensin; Prostate cancer; Protein kinase C

Indexed keywords

12 (2 CYANOETHYL) 6,7,12,13 TETRAHYDRO 13 METHYL 5 OXOINDOLO[2,3 A]PYRROLO[3,4 C]CARBAZOLE; 2 [1 (3 AMIDINOTHIOPROPYL) 1H INDOL 3 YL] 3 (1 METHYL 1H INDOL 3 YL)MALEIMIDE; 2 [1 (3 DIMETHYLAMINOPROPYL) 5 METHOXY 1H INDOL 3 YL] 3 (1H INDOL 3 YL)MALEIMIDE; BIS 1; BOMBESIN; CHELERYTHRINE; INOSITOL PHOSPHATE; NEUROTENSIN RECEPTOR; PHORBOL MYRISTATE; PROTEIN KINASE C DELTA; PROTEIN KINASE C EPSILON; PROTEIN KINASE C INHIBITOR; QUERCETIN; ROTTLERIN; STAUROSPORINE; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CANCER CELL; CELL STIMULATION; CONTROLLED STUDY; DRUG INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

BINDING SITES; CELL LINE, TUMOR; DOWN-REGULATION; HUMANS; INHIBITORY CONCENTRATION 50; INOSITOL PHOSPHATES; MALE; PHORBOL ESTERS; PHOSPHORYLATION; PROSTATIC NEOPLASMS; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS; RECEPTORS, NEUROTENSIN;

EID: 40849084894     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2008.01.009     Document Type: Article

References (58)

1. Reinecke M. Neurotensin:immunohistochemical localization in central and peripheral nervous system and in endocrine cells and its functional role as neurotransmitter and endocrine hormone. Prog Histochem Cytochem 16 (1985) 1-175
2. Carraway R., and Leeman S.E. Radioimmunoassay for neurotensin, a hypothalamic peptide. J Biol Chem 251 22 (1976) 7035-7044
3. Zhao D., and Pothoulakis C. Effects of NT on gastrointestinal motility and secretion, and role in intestinal inflammation. Peptides 27 10 (2006) 2434-2444
4. Geisler S., Berod A., Zahm D.S., and Rostene W. Brain neurotensin, psychostimulants, and stress-emphasis on neuroanatomical substrates. Peptides 27 10 (2006) 2364-2384
5. Dobner P.R. Multitasking with neurotensin in the central nervous system. Cell Mol Life Sci 62 17 (2005) 1946-1963
6. Carraway R.E., and Plona A.M. Involvement of neurotensin in cancer growth: evidence, mechanisms and development of diagnostic tools. Peptides 27 10 (2006) 2445-2460
7. Evers B.M. Neurotensin and growth of normal and neoplastic tissues. Peptides 27 10 (2006) 2424-2433
8. Seethalakshmi L., Mitra S.P., Dobner P.R., Menon M., and Carraway R.E. Neurotensin receptor expression in prostate cancer cell line and growth effect of NT at physiological concentrations. Prostate 31 3 (1997) 183-192
9. Hassan S., Dobner P.R., and Carraway R.E. Involvement of MAP-kinase, PI3-kinase and EGF-receptor in the stimulatory effect of Neurotensin on DNA synthesis in PC3 cells. Regul Pept 120 1-3 (2004) 155-166
10. Guha S., Rey O., and Rozengurt E. Neurotensin induces protein kinase C-dependent protein kinase D activation and DNA synthesis in human pancreatic carcinoma cell line PANC-1. Cancer Res 62 6 (2002) 1632-1640
11. Warhurst G., Fogg K.E., Higgs N.B., Tonge A., and Grundy J. Ca(2+)-mobilising agonists potentiate forskolin- and VIP-stimulated cAMP production in human colonic cell line, HT29-cl.19A: role of [Ca2+]i and protein kinase C. Cell Calcium 15 2 (1994) 162-174
12. Wang Q., Zhou Y., and Evers B.M. Neurotensin phosphorylates GSK-3alpha/beta through the activation of PKC in human colon cancer cells. Neoplasia 8 9 (2006) 781-787
13. Carraway R.E., Gui X., and Cochrane D.E. Ca2+ channel blockers enhance neurotensin (NT) binding and inhibit NT-induced inositol phosphate formation in prostate cancer PC3 cells. J Pharmacol Exp Ther 307 2 (2003) 640-650
14. Amar S., Kitabgi P., and Vincent J.P. Activation of phosphatidylinositol turnover by neurotensin receptors in the human colonic adenocarcinoma cell line HT29. FEBS Lett 201 1 (1986) 31-36
15. Bozou J.C., Rochet N., Magnaldo I., Vincent J.P., and Kitabgi P. Neurotensin stimulates inositol trisphosphate-mediated calcium mobilization but not protein kinase C activation in HT29 cells. Involvement of a G-protein. Biochem J 264 3 (1989) 871-878
16. Hermans E., and Maloteaux J.M. Mechanisms of regulation of neurotensin receptors. Pharmacol Ther 79 2 (1998) 89-104
17. Lefkowitz R.J., Pierce K.L., and Luttrell L.M. Dancing with different partners: protein kinase a phosphorylation of seven membrane-spanning receptors regulates their G protein-coupling specificity. Mol Pharmacol 62 5 (2002) 971-974
18. Krupnick J.G., and Benovic J.L. The role of receptor kinases and arrestins in G protein-coupled receptor regulation. Annu Rev Pharmacol Toxicol 38 (1998) 289-319
19. Kohout T.A., and Lefkowitz R.J. Regulation of G protein-coupled receptor kinases and arrestins during receptor desensitization. Mol Pharmacol 63 1 (2003) 9-18
20. Claing A., Laporte S.A., Caron M.G., and Lefkowitz R.J. Endocytosis of G protein-coupled receptors: roles of G protein-coupled receptor kinases and beta-arrestin proteins. Prog Neurobiol 66 2 (2002) 61-79
21. *. J Biol Chem 276 22 (2001) 19452-19460
22. Kemp B.E., and Pearson R.B. Protein kinase recognition sequence motifs. Trends Biochem Sci 15 9 (1990) 342-346
23. Dempsey E.C., Newton A.C., Mochly-Rosen D., Fields A.P., Reyland M.E., Insel P.A., and Messing R.O. Protein kinase C isozymes and the regulation of diverse cell responses. Am J Physiol Lung Cell Mol Physiol 279 3 (2000) L429-L438
24. Iwabu A., Smith K., Allen F.D., Lauffenburger D.A., and Wells A. Epidermal growth factor induces fibroblast contractility and motility via a protein kinase C delta-dependent pathway. J Biol Chem 279 15 (2004) 14551-14560
25. Pierchala B.A., Ahrens R.C., Paden A.J., and Johnson Jr. E.M. Nerve growth factor promotes the survival of sympathetic neurons through the cooperative function of the protein kinase C and phosphatidylinositol 3-kinase pathways. J Biol Chem 279 27 (2004) 27986-27993
26. Newton A.C. Protein kinase C: structure, function, and regulation. J Biol Chem 270 48 (1995) 28495-28498
27. Hofmann J. The potential for isoenzyme-selective modulation of protein kinase C. Faseb J 11 8 (1997) 649-669
28. Toullec D., Pianetti P., Coste H., Bellevergue P., Grand-Perret T., Ajakane M., Baudet V., Boissin P., Boursier E., Loriolle F., et al. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem 266 24 (1991) 15771-15781
29. Davies S.P., Reddy H., Caivano M., and Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 351 Pt 1 (2000) 95-105
30. Martiny-Baron G., Kazanietz M.G., Mischak H., Blumberg P.M., Kochs G., Hug H., Marme D., and Schachtele C. Selective inhibition of protein kinase C isozymes by the indolocarbazole Go 6976. J Biol Chem 268 13 (1993) 9194-9197
31. Gschwendt M., Muller H.J., Kielbassa K., Zang R., Kittstein W., Rincke G., and Marks F. Rottlerin, a novel protein kinase inhibitor. Biochem Biophys Res Commun 199 1 (1994) 93-98
32. Soltoff S.P. Rottlerin is a mitochondrial uncoupler that decreases cellular ATP levels and indirectly blocks protein kinase Cdelta tyrosine phosphorylation. J Biol Chem 276 41 (2001) 37986-37992
33. Hebert J., Augereau J., Gleye J., and Maffrand J. Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun 172 (1990) 993-999
34. Ferriola P.C., Cody V., and Middleton Jr. E. Protein kinase C inhibition by plant flavonoids. Kinetic mechanisms and structure-activity relationships. Biochem Pharmacol 38 10 (1989) 1617-1624
35. Carraway R.E., Hassan S., and Cochrane D.E. Regulation of neurotensin receptor function by the arachidonic acid-lipoxygenase pathway in prostate cancer PC3 cells. Prostaglandins Leukot Essent Fatty Acids 74 2 (2006) 93-107
36. Silva J.M., Li M.Z., Chang K., Ge W., Golding M.C., Rickles R.J., Siolas D., Hu G., Paddison P.J., Schlabach M.R., Sheth N., Bradshaw J., Burchard J., Kulkarni A., Cavet G., Sachidanandam R., McCombie W.R., Cleary M.A., Elledge S.J., and Hannon G.J. Second-generation shRNA libraries covering the mouse and human genomes. Nat Genet 37 11 (2005) 1281-1288
37. Nishikawa K., Toker A., Johannes F.J., Songyang Z., and Cantley L.C. Determination of the specific substrate sequence motifs of protein kinase C isozymes. J Biol Chem 272 2 (1997) 952-960
38. Wilkinson S.E., Parker P.J., and Nixon J.S. Isoenzyme specificity of bisindolylmaleimides, selective inhibitors of protein kinase C. Biochem J 294 Pt 2 (1993) 335-337
39. Heuser J.E., and Anderson R.G. Hypertonic media inhibit receptor-mediated endocytosis by blocking clathrin-coated pit formation. J Cell Biol 108 2 (1989) 389-400
40. Grady E.F., Slice L.W., Brant W.O., Walsh J.H., Payan D.G., and Bunnett N.W. Direct observation of endocytosis of gastrin releasing peptide and its receptor. J Biol Chem 270 9 (1995) 4603-4611
41. Zhuang S., Hirai S.I., and Ohno S. Hyperosmolality induces activation of cPKC and nPKC, a requirement for ERK1/2 activation in NIH/3T3 cells. Am J Physiol Cell Physiol 278 1 (2000) C102-C109
42. Benya R.V., Kusui T., Battey J.F., and Jensen R.T. Chronic desensitization and down-regulation of the gastrin-releasing peptide receptor are mediated by a protein kinase C-dependent mechanism. J Biol Chem 270 7 (1995) 3346-3352
43. Bagowski C.P., Stein-Gerlach M., Choidas A., and Ullrich A. Cell-type specific phosphorylation of threonines T654 and T669 by PKD defines the signal capacity of the EGF receptor. Embo J 18 20 (1999) 5567-5576
44. Williams B.Y., Dion S.B., and Schonbrunn A. Role of receptor and protein kinase C activation in the internalization of the gastrin-releasing peptide receptor. Mol Pharmacol 54 5 (1998) 889-898
45. Davis P.D., Hill C.H., Lawton G., Nixon J.S., Wilkinson S.E., Hurst S.A., Keech E., and Turner S.E. Inhibitors of protein kinase C. 1. 2,3-Bisarylmaleimides. J Med Chem 35 1 (1992) 177-184
46. Carraway R.E., Hassan S., and Cochrane D.E. Polyphenolic antioxidants mimic the effects of 1,4-dihydropyridines on neurotensin receptor function in PC3 cells. J Pharmacol Exp Ther 309 1 (2004) 92-101
47. Chii-Shiarng, and Poenie M. New fluorescent probes for protein kinase C. J. Biol Chem. 268 (1993) 15812-15822
48. Brodie C., and Blumberg P.M. Regulation of cell apoptosis by protein kinase c delta. Apoptosis 8 1 (2003) 19-27
49. Majumder P.K., Pandey P., Sun X., Cheng K., Datta R., Saxena S., Kharbanda S., and Kufe D. Mitochondrial translocation of protein kinase C delta in phorbol ester-induced cytochrome c release and apoptosis. J Biol Chem 275 29 (2000) 21793-21796
50. Han Z., Pantazis P., Lange T.S., Wyche J.H., and Hendrickson E.A. The staurosporine analog, Ro-31-8220, induces apoptosis independently of its ability to inhibit protein kinase C. Cell Death Differ 7 6 (2000) 521-530
51. Knapp L.T., and Klann E. Superoxide-induced stimulation of protein kinase C via thiol modification and modulation of zinc content. J Biol Chem 275 31 (2000) 24136-24145
52. Kitamura K., Mizuno K., Etoh A., Akita Y., Miyamoto A., Nakayama K., and Ohno S. The second phase activation of protein kinase C delta at late G1 is required for DNA synthesis in serum-induced cell cycle progression. Genes Cells 8 4 (2003) 311-324
53. Wu D., Foreman T.L., Gregory C.W., McJilton M.A., Wescott G.G., Ford O.H., Alvey R.F., Mohler J.L., and Terrian D.M. Protein kinase cepsilon has the potential to advance the recurrence of human prostate cancer. Cancer Res 62 8 (2002) 2423-2429
54. Mischak H., Goodnight J.A., Kolch W., Martiny-Baron G., Schaechtle C., Kazanietz M.G., Blumberg P.M., Pierce J.H., and Mushinski J.F. Overexpression of protein kinase C-delta and -epsilon in NIH 3T3 cells induces opposite effects on growth, morphology, anchorage dependence, and tumorigenicity. J Biol Chem 268 9 (1993) 6090-6096
55. Fujii T., Garcia-Bermejo M.L., Bernabo J.L., Caamano J., Ohba M., Kuroki T., Li L., Yuspa S.H., and Kazanietz M.G. Involvement of protein kinase C delta (PKCdelta) in phorbol ester-induced apoptosis in LNCaP prostate cancer cells. Lack of proteolytic cleavage of PKCdelta. J Biol Chem 275 11 (2000) 7574-7582
56. Sehgal I., Powers S., Huntley B., Powis G., Pittelkow M., and Maihle N.J. Neurotensin is an autocrine trophic factor stimulated by androgen withdrawal in human prostate cancer. Proc Natl Acad Sci USA 91 11 (1994) 4673-4677
57. Vias M., Burtt G., Culig Z., Veerakumarasivam A., Neal D.E., and Mills I.G. A role for neurotensin in bicalutamide resistant prostate cancer cells. Prostate 67 2 (2007) 190-202
58. Gavrielides M.V., Gonzalez-Guerrico A.M., Riobo N.A., and Kazanietz M.G. Androgens regulate protein kinase Cdelta transcription and modulate its apoptotic function in prostate cancer cells. Cancer Res 66 24 (2006) 11792-11801